Pharmaceutical and Medical Device

For more than 25 years, leading pharmaceutical and medical device companies have relied on Watkins & Eager to advance their interests in the courtroom and beyond.  We have successfully represented a broad range of these manufacturers in bellwether litigation (as well as multiple- and single-plaintiff cases) involving alleged product defect, winning numerous summary judgments and defense verdicts in federal and state courts throughout the country. Many of these cases have involved complex, high-profile claims that generated widespread interest and publicity. Our demonstrated ability to take a case to trial and prevail enables us to exert pressure throughout a litigated matter, often resulting in a favorable outcome without the need for trial. Whether favorably resolving cases through aggressive formal and informal discovery, pretrial motions, alternative dispute resolution, or at trial or on appeal, we have an established reputation for success.

Our firm devotes substantial resources to the defense of pharmaceutical and medical device manufacturers.  Nationally ranked in Product Liability by Chambers USA on a regular basis, we have served as national and “virtual” coordinating, motion, trial, and appellate counsel for such companies.

Watkins & Eager has been involved in numerous federal MDLs and state consolidated proceedings around the country, including those established for Xarelto (national trial team), Baycol (national trial team), Genetically Modified Rice, HRT (national team), Mirena, PPA (national law and motion counsel), Rezulin, Thimerosal (co-national counsel), Trasylol, Yaz/Yasmin, Stadol, and Reglan. We have extensive experience retaining and developing expert witnesses, and have prepared and defended dozens of current and former company employees, including executives, in depositions across the United States and in Asia and Europe.